Experimental studies indicate that the deletion of KEAP1 results in tumor aggressiveness and resistance to radiotherapy [27], with KEAP1 mutations in non-small cell lung cancer (NSCLC) was identified as associated with an increased risk of local recurrence after radiation therapy [28]. The gene discussed is KEAP1; the disease is neoplasm.